Browse the evidence

Intensive lifestyle modifications, specifically combining calorie-reduced/low-sodium diets (e.g., DASH) with regular exercise, are the foundational first-line management strategy for obesity-related hypertension, aiming for 5-10% body weight loss.

Start with a DASH-style diet (low sodium, high fruits/veg) and regular exercise. Aim to lose 5-10% of your body weight over 6 months. This is the most effective non-drug way to lower blood pressure. Be prepared that maintaining this requires ongoing support because the 'yo-yo effect' is real.

Semaglutide (2.4 mg weekly) and Liraglutide (3 mg daily) are effective pharmacological interventions for obesity-related hypertension, with Semaglutide showing superior weight loss and blood pressure reduction compared to Liraglutide.

If lifestyle changes aren't enough, GLP-1 drugs like Semaglutide (Wegovy) are highly effective. You get a 14.9% weight loss and 6.2 mmHg BP drop on average. It's a once-weekly injection, which is more convenient than daily options.

Bariatric surgery (specifically gastric bypass) is a highly effective intervention for obesity-related hypertension, capable of inducing hypertension remission in over half of patients and significantly reducing antihypertensive medication use.

If you have severe obesity (BMI ≥35, or ≥30 with health issues), gastric bypass surgery is a powerful option. It can put hypertension into remission for 51% of patients and drastically cut the number of blood pressure meds you need.

Endurance athletes require a daily protein intake of approximately 1.8 g/kg body mass per day, which may increase to >2.0 g/kg/day during carbohydrate-restricted training or on rest days.

Aim for 1.8 grams of protein per kilogram of body weight every day. If you are doing low-carb training sessions or taking rest days, bump this up to over 2.0 grams per kilogram. This helps your body repair muscle and replace amino acids lost during exercise.

Dual GLP-1/GIP receptor agonists (e.g., tirzepatide) produce significantly greater weight loss and glycemic control than selective GLP-1 receptor agonists by synergistically targeting both incretin pathways.

If you have T2DM or obesity, dual GLP-1/GIP agonists like tirzepatide are currently the most effective pharmacological option for weight loss and blood sugar control, outperforming older GLP-1 drugs. They are taken as a once-weekly injection. Discuss with your doctor if this advanced therapy is appropriate for your specific health profile.

Reducing saturated fat intake significantly improves lipid profiles (Total Cholesterol and LDL-C) and body weight metrics in adults.

Lowering saturated fat intake not only helps your heart but also tends to lower your LDL ('bad') cholesterol and total cholesterol, and may help with modest weight loss. This is achieved by swapping high-saturated-fat foods for healthier unsaturated fat sources or plant-based alternatives.

Post-bariatric pharmacotherapy with GLP-1 receptor agonists (specifically liraglutide) effectively augments weight loss and prevents weight regain in patients who have undergone Roux-en-Y gastric bypass or sleeve gastrectomy.

If you have had bariatric surgery and are regaining weight, talk to your doctor about adding a GLP-1 medication like liraglutide. It is taken as a daily injection, starting at a low dose to minimize side effects like nausea, and can help you lose additional weight or stop regaining it. This is a standard, evidence-based next step when surgery alone is not enough.

In patients with type 2 diabetes, adopting any healthy dietary pattern (Mediterranean, low-carb, plant-based, etc.) significantly improves body weight and glycemic control (HbA1c) compared to usual diet within the first six months, though these benefits attenuate and lose statistical significance after 12 months.

If you have Type 2 Diabetes, changing your diet to a healthier pattern (like Mediterranean, low-carb, or plant-based) will help you lose weight and lower your blood sugar significantly within the first 6 months compared to doing nothing. However, these benefits tend to fade after a year if adherence drops. There is no single 'best' diet; choose the one you can stick to long-term, as consistency matters more than the specific macronutrient split.

Low-bar wide stance squats increase hip extensor demand (greater hip contribution to total moment and higher gluteus maximus activity relative to high-bar narrow stance) compared to high-bar narrow stance squats.

If you want to prioritize your quads, use a high-bar narrow stance. If you want to prioritize your hips and glutes, switch to a low-bar wide stance. These technical changes directly shift the mechanical load to the target muscles.

Weight loss of 7-10% is required to improve histological disease activity and features of MASLD, while 3-5% weight loss stabilizes or improves fibrosis in normal-weight patients.

If you have MASLD, aim for a 7-10% reduction in body weight if you are overweight or obese, or 3-5% if you are normal weight. This is achieved by creating a daily calorie deficit of 500-1,000 kcal. Even if you cannot reach the higher target, losing just 5% of your body weight is highly likely to stabilize or improve liver fibrosis.

Adherence to a Mediterranean diet improves liver steatosis and metabolic parameters, and is the only diet pattern recommended as potential therapy for MASLD by major scientific societies.

Adopt a Mediterranean diet pattern: fill half your plate with vegetables, use olive oil as your primary fat, eat whole grains, and include fish and legumes regularly. Limit red meat and sweets. This pattern is the only one officially recommended for treating MASLD because it improves liver fat, blood sugar, and cholesterol simultaneously.

Moderate-to-vigorous physical activity (150-200 minutes/week) reduces intrahepatic lipid and improves MASLD outcomes, with vigorous exercise offering full benefits for steatohepatitis and fibrosis.

Aim for 150-200 minutes of moderate-to-vigorous physical activity per week, spread over 3-5 sessions. This can include brisk walking, cycling, or running. If you have joint issues, resistance training is also effective. Exercise reduces liver fat even if you don't lose weight, so start moving regardless of scale changes.

Excessive fructose consumption (e.g., >7 sugary drinks/week) is associated with hepatic fibrosis independent of calorie intake, and fructose-restricted diets decrease liver triglycerides.

Avoid sugary drinks and limit free sugars. High fructose intake causes liver fibrosis even if you don't gain weight. Switching to a fructose-restricted diet for just 6-8 weeks can reduce liver fat.

Initiating moderate-to-vigorous exercise after a new diagnosis of type 2 diabetes significantly reduces the risk of myocardial infarction, stroke, and all-cause mortality compared to remaining sedentary.

If you were just diagnosed with type 2 diabetes, start moving now. You do not need to be an athlete. Aim for at least 150 minutes of moderate activity (like brisk walking) per week. This single change can lower your risk of heart attack, stroke, and death by about 15-16% compared to staying sedentary.

The combination of smoking cessation and exercise initiation after a new diabetes diagnosis yields the greatest reduction in cardiovascular disease risk (46% reduction) and all-cause mortality (22% reduction) compared to continuing both bad habits.

For the best heart and life protection after a diabetes diagnosis, quit smoking and start exercising. Doing both together cuts your risk of heart disease by nearly half and death by over 20% compared to staying a smoker and sedentary. If you can only do one, start with exercise, but quitting smoking is also critical.

Older adults require protein intakes 50–100% higher than the standard RDA (~0.8 g/kg/day) to overcome anabolic resistance and preserve muscle mass.

If you are older, the standard protein recommendation is likely too low to stop muscle loss. Aim for roughly 1.2 to 1.6 grams of protein per kilogram of body weight every day, and combine this with regular resistance and aerobic exercise to effectively preserve your muscle mass.

Resistance exercise is the primary mechanical stimulus to prevent the decline in Type 2 muscle fiber cross-sectional area in older adults.

Engage in regular resistance training to maintain the size and function of your fast-twitch muscle fibers. This mechanical stimulus is crucial for keeping your muscles strong and functional as you age.

Short-term periods of physical inactivity (disuse) accelerate muscle atrophy and strength loss in older adults, mimicking years of natural aging.

Avoid prolonged periods of inactivity, such as bedrest or hospitalization, as they cause rapid muscle loss in older adults that is difficult to reverse. Maintain daily movement even during minor illnesses or injuries.

Drop set training produces similar muscular strength and hypertrophy adaptations compared to traditional training, while offering greater time efficiency.

If you are short on time, drop sets are a valid alternative to traditional sets for building muscle and strength. You do not need to sacrifice results for speed. Perform exercises to failure, then immediately reduce the weight by 10-20% and continue to failure. This can reduce your workout time by 30-70% while producing similar adaptations to traditional training. Note that current evidence is limited to young men.

GLP-1 receptor agonists (semaglutide, liraglutide, tirzepatide) induce significant weight loss (≥10%) and reduce major adverse cardiovascular events (MACE) in patients with obesity, outperforming conventional anti-obesity drugs and lifestyle modification alone.

If you have obesity and are at risk for heart disease, GLP-1 receptor agonists like semaglutide or liraglutide are currently the most effective pharmacological options for achieving significant weight loss (often >10%) and reducing cardiovascular risk. Unlike older weight-loss drugs or lifestyle changes alone, these medications address the hormonal drivers of weight regain and offer specific heart benefits. However, they require long-term use to maintain results, and treatment should be discussed with a healthcare provider to weigh benefits against costs and side effects.

Increases in diet quality and physical activity are the most significant determinants of weight loss during periods of lifestyle disruption.

To lose weight during stressful times, focus on improving what you eat (diet quality) and moving more (physical activity). These are the two most powerful tools for managing weight when your routine is disrupted.

Tirzepatide, a GIP/GLP-1 receptor agonist, achieves unprecedented reductions in HbA1c and clinically significant weight loss in Type 2 Diabetes patients, with a substantial proportion achieving normoglycemia without hypoglycemia.

Tirzepatide is a once-weekly injection that significantly lowers blood sugar and promotes substantial weight loss in people with Type 2 Diabetes, often without causing low blood sugar. It is designed to be started at a low dose and gradually increased to minimize side effects like nausea. This treatment challenges the old view that effective diabetes management requires insulin or causes weight gain.

Multi-receptor incretin drugs (Tirzepatide, Retatrutide, Mazdutide, Survodutide) produce substantial weight loss (>8kg) and glycemic control (HbA1c reduction >1%) in adults with overweight/obesity, with non-diabetic populations showing more pronounced effects than those with type 2 diabetes.

If you have overweight or obesity, multi-receptor incretin drugs like Tirzepatide or Retatrutide are highly effective for significant weight loss (often >10kg) and improving blood sugar control. These benefits are even more pronounced if you do not have type 2 diabetes. While gastrointestinal side effects are common, serious safety risks are not significantly higher than placebo. Consult a healthcare provider to determine if these medications are appropriate for your specific health profile.

Diabetes-specific nutrition formulas (DSNFs) containing slowly-digestible carbohydrates and healthy fats significantly reduce postprandial glucose and insulin excursions compared to standard formulas or isocaloric test meals in patients with type 2 diabetes.

For Type 2 Diabetes, replacing one or two meals/snacks daily with a Diabetes-Specific Nutrition Formula (DSNF) can significantly improve blood sugar control compared to standard formulas or regular food. Look for formulas with slowly-digestible carbs and healthy fats. Dosing should be tailored to your weight and current blood sugar levels, typically 1-3 servings per day.